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Human peripheral-blood monocytes are used as an established in vitro system for
generating macrophages. For several reasons, monocytic cell lines such as THP-1
have been considered as a possible alternative. In view of their distinct developmental
origins and phenotypic attributes, we set out to assess the extent to which human
monocyte-derived macrophages (MDMs) and phorbol-12-myristate-13-acetate (PMA)-
differentiated THP-1 cells were overlapping across a variety of responses to activating
stimuli. Resting (M0) macrophages were polarized toward M1 or M2 phenotypes by
48-h incubation with LPS (1 µg/ml) and IFN-γ (10 ng/ml) or with IL-4 (20 ng/ml)
and IL-13 (5 ng/ml), respectively. At the end of stimulation, MDMs displayed more
pronounced changes in marker gene expression than THP-1. Upon assaying an
array of 41 cytokines, chemokines and growth factors in conditioned media (CM)
using the Luminex technology, secretion of 29 out of the 41 proteins was affected
by polarized activation. While in 12 of them THP-1 and MDM showed comparable
trends, for the remaining 17 proteins their responses to activating stimuli did markedly
differ. Quantitative comparison for selected analytes confirmed this pattern. In terms of
phenotypic activation markers, measured by flow cytometry, M1 response was similar
but the established MDM M2 marker CD163 was undetectable in THP-1 cells. In
a beads-based assay, MDM activation did not induce significant changes, whereas
M2 activation of THP-1 decreased phagocytic activity compared to M0 and M1. In
further biological activity tests, both MDM and THP-1 CM failed to affect proliferation of
mouse myogenic progenitors, whereas they both reduced adipogenic differentiation of
mouse fibro-adipogenic progenitor cells (M2 to a lesser extent than M1 and M0). Finally,
migration of human umbilical vein endothelial cells was enhanced by CM irrespective
of cell type and activation state except for M0 CM from MDMs. In summary, PMA-
differentiated THP-1 macrophages did not entirely reproduce the response spectrum of
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primary MDMs to activating stimuli. We suggest that THP-1 be regarded as a simplified
model of human macrophages when investigating relatively straightforward biological
processes, such as polarization and its functional implications, but not as an alternative
source in more comprehensive immunopharmacology and drug screening programs.
Keywords: macrophage activation, phagocytosis, phenotype, THP-1 macrophages, human macrophages,
migration, progenitor cells
INTRODUCTION
Bone marrow–derived monocytes give rise to macrophages in
some tissues, as well as during acute infection and inflammation
(Geissmann et al., 2010; Hettinger et al., 2013; Wynn et al.,
2013). Macrophages are a heterogeneous and plastic cell
population which, by integrating signals emanating from the
environment, can be activated into a spectrum of phenotypes
ranging from the pro-inflammatory classically activated (M1)
to anti-inflammatory alternatively activated macrophages (M2)
(Sica and Mantovani, 2012; Murray et al., 2014; Xue et al.,
2014). Dynamic changes in their activation states may also
occur, and the final phenotype depends on the tissue in
which they are found (e.g., osteoclasts, alveolar macrophages,
Kupffer cells) as well as on their specific function (e.g., M1
or M2 macrophages, tumor-associated macrophages; Davies
et al., 2013). Nonetheless, differentiated macrophages retain
expression of a number of species-specific surface markers
such as CD11b, F4/80, CD68 and CD163 (Gordon et al.,
2014).
When it comes to investigating the pathways involved in
macrophage activation and their pharmacological control, the
source of macrophages, the definition of the activators, and
the choice of surface markers and transcriptional regulation
used to describe the type of activation are critical factors
(Murray et al., 2014). A number of systematic validations of
human macrophage phenotypic markers, as well as of maturation
and activation methods, have recently been reported (Ambarus
et al., 2012; Vogel et al., 2014; Tedesco et al., 2015). Surface
markers are known to predict functional properties: for instance,
CD206 expression allows prospective identification of phagocytic
macrophages (A-Gonzalez et al., 2017). In addition, cell-cell
interaction is important in terms of macrophage function
in disease progression and tissue homeostasis. For instance,
macrophage-derived factors are known to affect, among others,
response to infection, resolution of inflammation, adipose tissue
biology and cancer progression (Sica and Mantovani, 2012;
Wynn et al., 2013).
To overcome the issues of limited lifespan and inter-
individual variability that affects monocyte-derived human
macrophages, the THP-1 acute monocytic leukemia cell line
is frequently used in different research areas (Chanput et al.,
2014). Following differentiation using phorbol 12-myristate
13-acetate (PMA) or other stimuli, THP-1 cells acquire a
macrophage-like phenotype, which mimics primary human
macrophages in several respects (Maeß et al., 2014; Lund
et al., 2016). However, the malignant background of THP-1
cells might entail different responses compared to primary
somatic cells in their natural environment. Hence, due to
their distinct developmental origins and phenotypic attributes,
the two cell models may not be overlapping across the
full response spectrum, including cross-talk with other cell
types.
Although differentiation and selected functional features
of THP-1 cells were previously examined as compared to
monocyte-derived macrophages (MDM; Kohro et al., 2004;
Daigneault et al., 2010; Shiratori et al., 2017), to the best of
our knowledge an extensive comparison of the two cell types
in terms of potential crosstalk with other cell types via secreted
factors following activation with pro- or anti-inflammatory
stimuli has not been carried out yet. Hence, we set out to
investigate the responses of THP-1-derived and human MDMs
to M1- or M2-associated stimuli using a variety of experimental
assays. In particular, besides analyzing the transcriptional and
secretional profiles of both cell types, we chose to investigate
the effect of their CM on three cell populations: satellite cells,
fibroadipogenic progenitors and endothelial cells. The first two
are main players in the repair and regeneration of skeletal
muscle, a process in which macrophages play a paramount
role (Juban and Chazaud, 2017); the third is instead involved
in a wide range of physiological and pathological processes,
from tissue repair to cancer growth in tight relationship with
the inflammatory responses. The output of these analyses may
be relevant to cell model selection for several applications,
such as immunopharmacology studies and drug screening
programs.
MATERIALS AND METHODS
Cell Cultures
THP-1
THP-1 cells (ATCC R© TIB-202TM) were purchased from the
American Type Culture Collection and cultured according
to their specific indications, using an RPMI 1640 medium
supplemented with non-heat-treated 10% fetal bovine
serum (FBS; Invitrogen), 2 mM L-glutamine, 0.05 mM
β-mercaptoethanol, 10 mM HEPES, 4500 mg/L glucose,
100 U/ml penicillin and 100 µg/ml streptomycin at 37◦C in
a humidified 5% CO2 atmosphere. THP-1 cells were kept at a
minimum density of 3 × 105 cells/ml and were passaged when
reaching 8 × 105 cells/ml. Upon thawing, cells were initially
expanded by adding a volume of fresh medium every 48 h until
they reached the above-mentioned maximum density, after
which they were passaged every 2 days with a complete medium
replacement.
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Human Monocyte-Derived Macrophages (MDM)
Blood was obtained from male, non-smoking healthy donors
aged 18–35, at the University of Padua Medical Center
Transfusion Unit, following institutional standard operating
procedures. PBMCs from buffy coats were isolated first by Ficoll-
Paque (GE Healthcare) density gradient centrifugation at 400 g
for 25 min followed by a second, high-density hyperosmotic
Percoll gradient (GE Healthcare) at 400 g for 15 min. Monocytes
were then seeded at 5 × 105/ml in RPMI 1640 medium
supplemented with 10% FBS (Invitrogen), 100 U/ml penicillin
and 100 µg/ml streptomycin in the presence of 20 nM CSF-1
(Repnik et al., 2003). Cells were cultured for 7 days at 37◦C and
5% CO2, with medium change every 3 days, to obtain MDMs.
Satellite Cells
Satellite cells were isolated from single myofibers of extensor
digitorum longus (EDL) muscles of C57BL/10ScSn mice
following a standard protocol (Pasut et al., 2013). Cells were
expanded on gelatine-coated cell plates in F12 nutrient mixture
(Ham) supplemented with 20% FBS (Gibco), 5 ng/ml FGFb,
100 U/ml penicillin and 100 µg/ml streptomycin, at 37◦C in a
humidified 5% CO2 atmosphere. Experiments were performed
on cells with less than 10 passages.
Fibro-Adipogenic Precursors (FAPs)
Fibro-adipogenic precursors (kindly provided by Dr. Luca
Madaro) were isolated by sorting from adult murine skeletal
muscles, as CD45−CD31−ter119−α7int−sca1+. Cells were
expanded in DMEM supplemented with 20% FBS (Gibco), 10%
HS (Gibco), 2.5 ng/ml FGFb, 100 U/ml penicillin and 100 µg/ml
streptomycin, on gelatin-coated cell plates. For adipogenic
differentiation proliferating medium was replaced by DMEM
supplemented with 10% FBS (Gibco), 0.25 µM dexamethasone,
0.5 mM 3-isobutyl-1-methylxanthine (IBMX), 10 µg/ml insulin,
100 U/ml penicillin and 100 µg/ml streptomycin. After 3 days
in differentiation medium cells were exposed to an adipogenic
maintenance medium DMEM supplemented with 10% FBS
(Gibco), 10 µg/ml insulin, 100 U/ml penicillin and 100 µg/ml
streptomycin.
Human Umbilical Vein Endothelial Cells
(HUVECs)
Human umbilical vein endothelial cells were isolated from
normal-term umbilical cords as previously published (Bolego
et al., 2006). Cells were grown in medium M199 (Invitrogen)
supplemented with 15% FBS (Invitrogen), 40 µg/ml gentamicin,
endothelial cell growth factor (ECGF, 100 µg/ml; Sigma–
Aldrich), and heparin (100 UI/ml, Sigma–Aldrich), at 37◦C in
a humidified 5% CO2 atmosphere. HUVECs were identified by
their morphology and detection of CD31-related antigen, and
used for experiments from passages 2 through 5.
Preparation of Conditioned Media (CM)
THP-1
Cell differentiation was induced via a 6-h exposure to 185 ng/ml
phorbol 12-myristate 13-acetate (PMA, Sigma–Aldrich) in
DMSO. Cells were then polarized toward M1 or M2 phenotype
by incubation for 48 more hours with INF-γ (20 ng/ml,
Immunotools) and LPS (100 ng/ml, Sigma–Aldrich) or with IL-4
(20 ng/ml, Immunotools) and IL-13 (20 ng/ml, Immunotools),
respectively (Tjiu et al., 2009; Maeß et al., 2014), still in the
presence of PMA. Cells used for the resting condition were
kept in the presence of PMA for 48 more hours in normal
growth medium. CM were then prepared by keeping polarized
as well as resting cells in serum-free RPMI without stimuli and
no PMA for 72 more hours. Media were then collected and
concentrated 10-fold using Amicon Ultra-15 centrifugal filter
units with Ultracel-PL, cut-off 3 KDa (Millipore/Merck). Total
protein content was then determined by Bradford assay, using
bovine serum albumin as reference. CM were stored at −20◦C
until use.
MDM
After removing the culture medium, resting macrophages were
either incubated with fresh, serum-free RPMI to generate M0 or
activated toward M1 or M2 phenotype by incubation for 48 h
with either LPS (1 µg/ml, Sigma–Aldrich) and IFN-γ (10 ng/ml,
Immunotools), or IL-4 (20 ng/ml, Immunotools) and IL-13
(5 ng/ml; Immunotools), respectively (Tedesco et al., 2015). To
obtain CM, MDMs activated as described above were incubated
for a further 72 h in serum-free RPMI without stimuli. Media
were then collected and concentrated as described above for
THP-1.
qRT Analyses
For qRT analyses, THP-1 cells and MDMs were lysed
immediately after the 48-h polarization step using the
TRIzol R© Reagent (Life Technologies); total RNA isolation
was performed according to the manufacturer’s protocol.
cDNA was generated using EuroScript Reverse Transcriptase
(Euroclone Cytogenetics), with random examers and 2.5 µg
RNA per reaction. qRT-PCR reactions were then prepared with
the PowerUp SYBR Green Mix (Applied Biosystems) and run
using a QuantStudio 6 Flex Real-Time PCR System (Applied
Biosystems). Primer pairs were selected from PrimerBank (The
Massachusetts General Hospital, Boston, MA, United States)
or, when not available, designed ex novo with NCBI Primer-
BLAST. Verification and location of target gene sequences were
performed on Ensembl Genome Browser. All primer sequences
are reported in Table 1. Results were normalized using GAPDH
as housekeeping gene as reference and evaluated using the
2−11Ct method.
Luminex Assays
Composition of CM was analyzed using Eve Technologies’
Human Cytokine/Chemokine Array 41-Plex Discovery assay
(Eve Technologies Corp, Calgary, AB, Canada); THP-1 media
were analyzed with a modified version of the platform, Human
Cytokine/Chemokine Array 42-Plex Discovery assay, which
included IL-18. For these analyses, both THP-1 and MDM CM
were diluted to a twofold concentration compared to straight
medium (pilot tests were performed to find out the optimal
dilution). Given that MDM and THP-1 CM were analyzed in
different runs, a quantitative comparison for single analytes was
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performed only when the data fulfilled the following criteria: (a)
the standard curves of the two data sets had overlapping shapes,
and (b) the fluorescence intensity (FI) values obtained from all the
samples of at least one cell type fell within the central part of the
standard curve (i.e., were equal or higher than the third smallest
standard).
Flow Cytometry
Surface marker expression in resting (M0), M1 and M2-polarized
THP-1 and MDM cells was analyzed by flow cytometry. After
the 48-h polarization, cells were washed once with PBS, gently
scraped and transferred into FACS tubes. Cells were then
stained with fluorochrome-tagged monoclonal antibodies (all
from BD Biosciences) against surface CD80 (FITC) to typify
the M1 phenotype, and against CD206 (FITC) and CD163 (PE)
to characterize the M2 phenotype. The selection of markers
was based on previous characterizations (Fadini et al., 2013;
Tedesco et al., 2015; Toniolo et al., 2015) according to recent
guidelines (Murray et al., 2014). Upon labeling, cells were
washed, suspended in PBS and analyzed with a FacsCanto
II flow cytometer (BD Biosciences), recording at least 10,000
events for each sample. Data were analyzed using the FacsDiva
software (BD Biosciences). Isotype-matched controls were used
as baseline reference. Typically, less than 2% positive cells
were allowed beyond the statistical marker in appropriate
controls.
Phagocytosis Assays
Phagocytosis functional assay was performed in resting, M1- and
M2-polarized THP-1 cells and MDMs. After 48-h polarization,
cells were incubated with fluorescent beads (1.0 µm carboxylate-
modified yellow-green fluospheres, Molecular Probes) for 1 h
in serum-free RPMI at 37◦C, 5% CO2 (Schrijvers et al.,
2004). Cells were then washed three times with cold PBS to
remove fluorescent beads that had not been internalized. Finally,
macrophages were scraped from the plate and analyzed by flow
cytometry.
Proliferation Assays
Satellite cells were seeded into 24-well plates containing gelatine-
coated glass coverslips, at a density of 5000 cells/cm2 in growth
medium. The specified CM were then added to three wells per
experimental condition. The amount of conditioned medium
added to each well was chosen so that the total amount of
protein equalled that contained in J774 macrophage conditioned
medium (mCM, prepared as described in Malerba et al., 2009)
used at 2% v/v as a positive control. Cells were kept in the
presence of the CM at least 48 h, before being exposed to a
12-h pulse of 10 µM EdU (5-ethynyl-2′-deoxyuridine). After
labeling, cell proliferation was assessed with the Click-iT R© EdU
Alexa Fluor R© 488 Imaging Kit (Life Technologies) according to
the manufacturer’s protocol. Images for EdU-positive cells were
acquired with an epifluorescence microscope and the percentage
of labeled nuclei (i.e., of cells that had gone through S phase
during the labeling pulse) was determined by counting at least
10 randomly chosen fields per sample.
Adipogenesis Assays
Fibro-adipogenic precursors cells were grown and differentiated
in 24-well plates as described above, adding the specified CM
to three wells per each experimental condition. The amount of
conditioned medium added to each well was chosen so that
the total amount of protein equalled that contained in the
mCM used at 2% v/v as positive control. Once the 3 days in
adipogenic maintenance medium were completed, cultures were
fixed overnight in 4% PFA in PBS and stained with a 0.2% Oil-
Red O solution in 60% iso-propanol. Oil-red O positive cells were
counted at the bright-field optical microscope, either in at least 10
randomly chosen different fields or in the whole well.
Chemotaxis Assay
Chemotaxis experiments were performed in a 48-well modified
Boyden chamber (Neuro Probe) using 8-µm Nucleopore
polyvinylpyrrolidine-free polycarbonate filters coated with
TABLE 1 | Sequences of the primers used for qRT analyses.
Gene Forward Reverse Primer Bank ID Amplicon Size
IL-6 ACTCACCTCTTCAGAACGAATTG CCATCTTTGGAAGGTTCAGGTTG 224831235c1 149
TNF-α CCTCTCTCTAATCAGCCCTCTG GAGGACCTGGGAGTAGATGAG 25952110c1 220
HIF1α TGCTCATCAGTTGCCACTTC CGGCATCCAGAAGTTTTCTC n/a 107
IL-1β ATGATGGCTTATTACAGTGGCAA GTCGGAGATTCGTAGCTGGA 27894305c1 132
CD68 CTTCTCTCATTCCCCTATGGACA GAAGGACACATTGTACTCCACC n/a 105
MCP-1 GATCTCAGTGCAGAGGCTCG TTTGCTTGTCCAGGTGGTCC n/a 155
TLR2 GCTCGGAGTTCTCCCAGTTTC GAGCTGCCCTTGCAGATAC n/a 299
TLR4 CAGAGTTGCTTTCAATGGCATC AGACTGTAATCAAGAACCTGGAGG n/a 282
CD206 (MRC1) CTACAAGGGATCGGGTTTATGGA TTGGCATTGCCTAGTAGCGTA 145312260c3 105
PPARγ TACTGTCGGTTTCAGAAATGCC GTCAGCGGACTCTGGATTCAG 116284372c3 141
CD204 (MSR1) CCAGGTCCAATAGGTCCTCC CTGGCCTTCCGGCATATCC n/a 94
TGM2 CGTGACCAACTACAACTCGG CATCCACGACTCCACCCAG n/a 136
CCL22 (MDC) ATTACGTCCGTTACCGTCTG TAGGCTCTTCATTGGCTCAG n/a 175
IL-10 TACGGCGCTGTCATCGATTT TAGAGTCGCCACCCTGATGT n/a 191
Primers were selected from PrimerBank or designed using the online tool for Real-Time PCR Blast, as described in Section “Materials and Methods.”
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FIGURE 1 | Gene expression profiles of macrophage activation markers. mRNA levels of M1 markers (A) and M2 markers (B) were measured by qRT and
normalized to GAPDH. White triangles indicate the values found in M1-polarized cells; black squares indicate the values found in M2-polarized cells. Data are
expressed as 2−11Ct values using the Resting condition as reference (n = 3–4 independent experiments per condition).
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10 µg/ml collagen as described elsewhere (Trenti et al.,
2017). Lower chambers were filled with 28 µL CM or M199
supplemented with 100 U/mL heparin in the presence of
10 ng/mL VEGF as a positive control. Upper chambers were
filled with 50 µL HUVEC (1.6 × 105 cells/mL in M199
supplemented with 1% FBS and 100 U/mL heparin). For
assessment of basal motility, M199 supplemented with 100 U/mL
heparin was used in the lower chamber. After 6 h incubation
at 37◦C, non-migrating HUVECs in the upper surface of the
filter were removed by scraping. Cells migrated to the lower
side of the filter were stained with Diff-Quick stain (Medion
Diagnostics), and densitometric analysis was performed using
the Image J 1.47v software (NIH, United States). Six replicates
were performed for each independent experiment.
Statistical Analyses
Statistical analysis from at least 3 independent experiments was
performed. Results are presented as mean values, with error
bars representing the standard error (S.E.M.) of the average
value. Throughout this work we chose to use non-parametric
statistical tests, specifically, Kruskal–Wallis for variance analysis
and Mann–Whitney for pairwise analysis, because of the elevated
data dispersion found in our qRT and Luminex data sets. All tests
were performed using the Prism 6 suite (GraphPad Software).
Significance thresholds were chosen as described in detail in the
Section “Results.”
RESULTS
Analysis of Gene Expression upon M1
and M2 Polarization Shows More
Pronounced Changes in MDM than in
THP-1
Differentiated MDM and THP-1 were activated for 48 h with
either LPS/IFN-γ (M1) or IL-4/IL-13 (M2). Gene expression
TABLE 2 | Statistical analysis of qRT data, performed using the Mann–Whitney
non-parametric test.
MDM THP-1
IL-6 ∗ M1 > M2 ns
TNF-α ns ns
HIF-1α ∗ M1 > M2 ns
IL-1β ∗ M1 > M2 ns
TLR2 ∗ M1 > M2 ns
TLR4 ns ns
MCP-1 ns ∗ M1 > M2
MRC ∗ M2 > M1 ns
PPAR-γ ∗ M2 > M1 ns
CD68 ∗ M2 > M1 ns
CD204 ∗ M2 > M1 ns
TGM2 ∗ M2 > M1 ∗ M2 > M1
CCL22 (MDC) ns ∗ M2 > M1
IL-10 ns ns
∗0.1 ≥ p > 0.07, see Section “Results” for statistical considerations.
for a set of validated immunophenotypic markers for the two
polarization states (Ambarus et al., 2012; Vogel et al., 2014;
Chanput et al., 2014; Shiratori et al., 2017) was then tested
by qRT-PCR with the 2−11Ct method, using the unpolarized
(resting) condition as a reference. Upon M1 activation, mRNA
levels of IL-6, HIF-α, IL-1β and TLR2 were significantly increased
in MDM only, while MCP-1 did so in THP-1 cells only. No
significant difference was found between M1 and M2 in either
cell type for TNF-α, which tends to peak at earlier time points
(Shiratori et al., 2017), and TLR4, whereas CD68 mRNA levels
increased more in M2 than in M1, but once again only in
MDM (Figure 1A and Table 2). Following M2 activation, mRNA
levels of CD206, CD204 and PPARγ were significantly increased
in MDM but not in THP-1, whereas TGM2 mRNA levels
increased significantly in both cell types, CCL22/MDC increased
significantly in THP-1 only, and IL-10 was unchanged in both
groups (Figure 1B and Table 2).
Patterns of Cytokine Production upon
Activation Exhibit Significant Differences
between MDM and THP-1 Macrophages
The levels of 41 biologically active molecules (cytokines,
chemokines and growth factors, Table 3) were measured in
MDM and THP-1 conditioned supernatants using the Luminex
technology; results are summarized in Figure 2. In 12 instances,
polarization did not affect the protein’s secretion in either cell
type (upper gray fields, Figure 2). In other 12 instances, THP-
1 and MDM showed the same type of response to polarization
(middle fields, Figure 2). By contrast, in the 17 remaining cases
THP-1 and MDM differed in their responses to the polarization
stimuli (lower fields, Figure 2), although just at the p> 0.07 level
for IL-15 and IL-17A. It should be noticed that both cell types
displayed a high data dispersion, which was reflected in high
standard errors when averaging the independent experiments.
For this reason, when assessing statistical significance, we
considered a range of p-values rather than a single cut-off.
Indeed, had we used a single significance threshold, even obvious
biological differences would have not been acknowledged by our
non-parametric analyses, as clearly demonstrated by the example
of IL-1β (Supplementary Figure 1).
MDM and THP-1 CM were also compared quantitatively,
for those analytes in which the measurements fell within the
requirements needed to compare datasets obtained in different
runs (see Materials and Methods). The results of such analyses
are shown in Table 4. No consistent trend was seen in terms of
one cell type consistently producing higher amounts of active
molecules compared to the other, although THP-1 media tended
to come on top most of the time. The differences in expression
levels were also quite variable, as they ranged from a minimum of
twofold to almost three orders of magnitude.
Expression of M2 Phenotypic Activation
Markers in THP-1 Macrophages Does
Not Match That Found in MDM
Previous studies described marker expression in differently
activated MDM (Ambarus et al., 2012; Vogel et al., 2014; Tedesco
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TABLE 3 | Analytes evaluated with the Luminex assay.
M1-associated M2-associated Others
IL-1A IP-10 IL-1RA EGF
IL-1B MCP-1 IL-4 Eotaxin
IL-2 MCP-3 IL-10 Flt-3
IL-3 MIP-1A IL-12p40 FGF-2
IL-5 MIP-1B IL-13 MDC
IL-6 G-CSF TGF-α PDGF-AA
IL-7 GM-CSF PDGF-BB
IL-8 GRO
IL-9 Fractalkine
IL-12p70 RANTES
IL-15 TNF-α
IL-17A TNF-β
INFα2 VEGF-A
INFγ
Cytokines and chemokines known to be preferentially secreted by a specific
macrophage phenotype are indicated as M1 or M2.
et al., 2015) and THP-1 cells (Chanput et al., 2014; Shiratori et al.,
2017). Here we compared responses of three widely accepted
polarization markers (i.e., CD80, CD206, and CD163) upon
exposing the two cell types to the same polarization protocol.
While response for the M1 marker CD80 was quite clear in both
cell types (Figure 3), the M2 marker CD206 did not behave in
the expected fashion in THP-1 cells. Specifically, its expression
not only was in general confined to less than 4% of the cells but
there was no increase in M2 compared to M1, as opposed to
what was found in MDM. Furthermore, the M2 marker CD163,
which also displayed the expected trend in MDM, was completely
undetectable in THP-1 macrophages (Figure 3).
THP-1 Macrophages Can Reproduce the
Effects of MDM in Some Functional
Assays, But Not in Others
Phagocytosis is a major function of macrophages (Gordon, 2016).
Using a beads ingestion assay, MDMs generally showed increased
phagocytosis capacity as compared with THP-1. Activation of
MDMs led to non-significant changes (see also Shiratori et al.,
2017), whereas in THP-1 cells activation with IL-4/IL-13, but not
with LPS/IFN-γ, downregulated the amount of internalized beads
compared with resting (Figure 4), possibly as a result of limited
amounts of cell surface M2 markers (Figure 3).
Several lines of evidence indicate that macrophages play an
active role in controlling proliferation and differentiation in the
context of skeletal muscle regeneration (Juban and Chazaud,
2017). For this reason, we assessed the effect of conditioned MDM
versus THP-1 media on the proliferation of murine satellite cell-
derived myogenic progenitors. Satellite cells are adult myogenic
stem cells that are located under the basal lamina surrounding
each myofiber and are responsible for muscle regeneration
in response to injury. This model was chosen because our
data had indicated that mCM from LPS-activated J774 cells
had powerful pro-myogenic effects both in vitro and in vivo
(Malerba et al., 2009 and manuscript in preparation). As shown
FIGURE 2 | Statistical analysis of Luminex data. The heat map indicates the
results of the variance analysis performed with the Kruskal–Wallis test
considering the three experimental conditions (Resting, M1 and M2),
expressed as p-values. The color code is listed below the map. When p was
≤0.1, we carried out a post hoc analysis with the Mann–Whitney test,
comparing M1 versus Resting and M2 versus Resting. The results of such
analyses are reported inside each cell (see Supplementary Table 1 for
p-values).
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in Figure 5A, neither THP-1 nor MDM media affected the
proliferation rate, while the mCM increased the fraction of EdU+
cells, as expected.
The second cellular model onto which we tested THP-1
and MDM CM was the differentiation of muscle-derived FAPs.
These are also cells involved in muscle regeneration, as upon
damage FAPs release trophic factors acting on satellite cells, but
in pathological conditions their over-activation can lead to the
typical fibro-fatty deposition found in many muscle diseases.
Once again, we used mCM as positive control, as it has a potent
anti-adipogenic effect (manuscript in preparation). Exposure of
FAPs to all three THP-1 CM reduced adipogenic differentiation,
measured as % of Oil Red O-stained cells (Figure 5B and
Supplementary Figure 3); such effect was more evident with
resting and M1 than with M2. The same trend was observed
with MDM media, except that M2 and resting media yielded
comparable effects. At the same time, neither MDM nor THP-1
CM proved as potent as murine CM in their anti-adipogenic
effect.
Lastly, we assessed chemotactic effects of THP-1 and MDM
CM on human primary endothelial cells (HUVECs) using the
micro-chemotaxis chamber assay. In these experiments, human
VEGF was used as a positive control. In this model, the effect of
MDM media differed greatly from that of THP-1, as the latter
induced chemoattractant effects comparable to VEGF even in
the resting state, with no changes in response to any activating
stimuli. Conversely, in MDM only media from M1 and, to a lesser
extent, M2 cells induced an increase in HUVEC migration, while
no effect was seen with medium from resting cells (Figure 5C;
TABLE 4 | Quantitative comparison of Luminex analytes between MDM and
THP-1.
Cytokine p-value Differences in Log2 FC
TGF-α ∗ MDM < THP-1 Resting, M1, M2 3.9, 1.5, 3.3
MCP-3 ∗ MDM > THP-1 M1 2.3
MDC ∗ MDM > THP-1 M1 2.3
PDGF-AA ∗ MDM < THP-1 Resting, M1, M2 8.6, 8.7, 8.5
PDGF-BB ns
IL-1RA ∗ MDM < THP-1 Resting, M1, M2 5.6, 6.1, 6.6
IL-1β ∗ MDM < THP-1 M1 6.5
IL-4 ns
IL-6 ∗ MDM > THP-1 M1 6.4
IL-8 ∗ MDM < THP-1 Resting, M2 1.7, 3.0
IP-10 ns
MCP-1 ∗ MDM < THP-1 Resting, M2 1.1, 1.6
MIP-1A ∗ MDM < THP-1 Resting 2.8
MIP-1B ∗ MDM < THP-1 Resting, M1, M2 4.6, 2.6, 5.4
RANTES ∗ MDM < THP-1 Resting, M1, M2 4.4, 1.4, 3.3
TNF-α ∗ MDM < THP-1 M1 4.8
VEGF-A ∗ MDM < THP-1 Resting, M1, M2 6.4, 4.8, 5.4
For each analyte, pairwise comparisons were performed between MDM/Resting
versus THP-1/Resting, MDM/M1 versus THP-1/M1 and MDM/M2 versus THP-
1/M2, using the Mann–Whitney non-parametric analysis. ∗ Indicates 0.1≥ p> 0.07.
The third column indicates which cell type had the highest secretion levels, as well
as in which polarization state such difference was found. The last column shows
the fold change for each of the conditions, expressed as base-2 logarithm.
see also Supplementary Figure 4 for an example of raw migration
data).
DISCUSSION
Human peripheral-blood monocytes are the most commonly
used precursors for generating macrophages in vitro (Murray
et al., 2014). However, use of MDMs presents several issues,
such as the fact that they are unable to proliferate to a
significant extent (i.e., each prep requires a fresh supply of
cells) and cannot be stored in liquid nitrogen. Besides, and this
aspect can severely affect experimental data, donor-dependent
variability can be substantial. Conversely, using the THP-1 cell
line as a source for human macrophages does away with these
issues, as they can be easily expanded in vitro and stocked
in liquid nitrogen in their non-differentiated state, and their
single genetic background should minimize the variability of cell
phenotype (reviewed in Auwerx, 1991; Qin, 2012; Chanput et al.,
2014).
THP-1 cells are derived from a tumor, however, and as such
one cannot simply assume that the phenotypic and molecular
attributes of the macrophages derived from their differentiation
are necessarily equivalent to those of macrophages obtained
from circulating monocytes. For example, as opposed to primary
monocytes, monocyte-derived THP-1 cells express low levels
of CD14 (Bosshart and Heinzelmann, 2004), a membrane-
associated protein that forms a highly sensitive LPS signaling
complex with TLR4 and MD2 (Park et al., 2009), and decreases
with macrophage differentiation (Steinbach and Thiele, 1994).
Indeed, even though THP-1 derived macrophages are functional
and can be activated, their responsiveness in terms of gene
expression changes upon activation has been reported to be
smaller than that of naïve primary macrophages (Maeß et al.,
2014).
These considerations prompted us to carry out a systematic
comparison between MDM and THP-1 derived macrophages in
terms of gene expression, cytokine and chemokine secretion,
surface markers and functional responses on other cell types,
both in resting and activated conditions. We took advantage of
previous studies to select suitable differentiation and activation
protocols for THP-1 (Daigneault et al., 2010) and MDM (Tedesco
et al., 2015). Our qPCR analyses on 14 markers of polarization
confirmed that, at the transcription level, activation of THP-1
cells often led to a different, usually less pronounced response
compared to MDM. Such a limited polarization response of THP-
1 in comparison to MDM is consistent with a recently published
study (Shiratori et al., 2017). For example, the difference between
M1 and M2 THP-1 cells in terms of IL-1β mRNA levels
did not reach statistical significance; however, IL-1β protein
concentration in THP-1 M1 conditioned medium was much
higher than that in M2 and resting media (Figure 2 and
Supplementary Figure 2). This finding is in agreement with other
transcriptome/proteome comparisons of different macrophage
models, which reported that very few molecules are regulated at
both mRNA and protein levels across cell types and activation
states (Martinez et al., 2013; Xue et al., 2014).
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FIGURE 3 | Flow cytometry analyses of surface activation markers for MDM and THP-1. Cells were unstimulated (resting) or activated with LPS/IFNγ or IL-4/IL-13
for 48 h. Bar graphs report the percentage of CD80+, CD206+, and CD163+ cells in 3 independent experiments with THP-1 macrophages (A) and in MDMs
obtained from 4 different donors (B). Data are expressed as mean ± SEM. Variance analysis was performed using the Kruskal–Wallis test and the post hoc analysis
with the Mann–Whitney test. ∗0.1 ≥ p > 0.07, ∗∗0.07 ≥ p ≥ 0.05, ∗∗∗p ≤ 0.05.
FIGURE 4 | Macrophage phagocytic activity following incubation with dextran-FITC 1 µm beads. MDM and THP-1 were unstimulated (resting) or activated with
LPS/IFNγ or IL-4/IL-13 for 48 h then incubated with fluorescent microbeads for 1 h. Data are expressed as mean ± SEM of 3 independent experiments with THP-1
and of 7 different donors for MDMs. Variance analysis was performed with the Kruskal–Wallis test and the post hoc analysis with the Mann–Whitney test.
∗∗∗p ≤ 0.05.
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FIGURE 5 | Results of functional assays. (A) Effect of THP-1 and MDM CM on satellite cells proliferation. The number of proliferating cells is expressed as the ratio of
EdU positive cells in the different experimental conditions, normalized against the value found in non-treated cells (‘K’ column). Data are reported as mean ± SEM of
4 independent experiments with THP-1 and 5 independent experiments with MDM CM. mCM was used as positive control. (B) Effect of THP-1 and MDM CM on
FAP adipogenesis. Extent of FAP adipogenesis is expressed as the fraction of Oil Red-O stained cells, normalized against the value found in non-treated cells
(‘K’ column). Data are expressed as mean ± SEM of 7 independent experiments with THP-1 cells and 4 independent experiments with MDMs. mCM was used as
positive control. (C) THP-1 and MDM CM influenced HUVEC migration. HUVEC migration was measured in a Boyden micro-chemotaxis chamber after 6 h. VEGF
was used as a positive control. Data are expressed as mean ± SEM of 3 independent experiments for THP-1 and of 4 different donors for MDM, all performed in
sextuplicate. Variance analysis was performed with the Kruskal–Wallis test and the post hoc analysis with the Mann–Whitney test. ∗0.1 ≥ p > 0.07,
∗∗0.07 ≥ p ≥ 0.05.
A comprehensive analysis of secreted cytokines and growth
factors in resting and activated states showed distinct signatures
in the two cell types. Specifically, our data indicate that many
of the analytes such as monocyte chemotactic protein (MCP)-1,
MCP-3 and IL-4 did not show the same response to polarization
in the two cell types. For a subset of analytes we could
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reliably compare the amount of protein secreted by both cell
types. Once again, MDM and THP-1 macrophages exhibited
noticeable differences, as for the single factors the change in
concentration ranged from 2.5 to more than 400-fold, usually
in favor of THP-1 cells. For example, levels of secreted IL-1β
were about 90-fold higher in THP-1 than in MDM media, in
agreement with previously published data (Daigneault et al.,
2010), likely due to more complex IL-1β processing and two-step
secretion in MDMs (Netea et al., 2009). Secretion of TNF-α
following stimulation with LPS was also remarkably higher
in PMA-treated THP-1 in comparison to MDMs. In contrast,
secretion of MCP-3, macrophage-derived chemokine (MDC)
and IL-6 was more pronounced in MDMs in comparison to
THP-1. Of note, the secreted amount of each of the above
proteins was significantly upregulated by M1-associated stimuli
(Table 4) in MDMs, which was somewhat unexpected for
MDC, regarded as a M2 marker by other authors (Grotenhuis
et al., 2013). These findings suggest that the two macrophage
models are unlikely to be fully interchangeable when testing
functional effects of their conditioned media on other cell types
in vitro.
In terms of phenotypic surface markers, while M1 polarization
led to the expected outcome in both cells types, M2 polarization
did not seem to affect THP-1 macrophages. Specifically,
not only CD206 expression did not differ between M1 and
M2 cells, but there was a trend toward increased CD206
levels in M1 in comparison to M2 THP-1 macrophages.
Furthermore, these latter did not express detectable amounts
of the hemoglobin receptor CD163, an established M2 marker
regulated, among others, by glucocorticoids (Vallelian et al.,
2010; Tedesco et al., 2015). Such limited response to M2
polarization has also been reported in a very recent study
(Shiratori et al., 2017), in which, however, the Authors did
report a basal expression of CD163, albeit unresponsive
to polarization, both in MDM and in THP-1-derived
macrophages.
Importantly, our set of functional assays also yielded mixed
results in terms of equivalence of MDMs and THP-1. In the
beads internalization assay, the phagocytic capacity of MDM
was not modulated by M1- or M2-associated stimuli, whereas
that of THP-1 macrophages was downregulated by IL-4/IL-13
activation. These findings are consistent with the view that
phagocytosis is a general property of macrophages (Gordon,
2016), but not necessarily a reliable predictor of M1 or M2
responses (Mills and Ley, 2014). It should also be noted that
the outcome of phagocytosis assays by macrophages can be
affected by the phagocytosis-triggering agent, e.g., opsonised
beads as opposed to bacterial antigens (Daigneault et al.,
2010; Sumiya et al., 2015; Shiratori et al., 2017). In the
second set of analyses, based on cells that are key players
in skeletal muscle regeneration, MDM and THP-1 CM had
comparable effects on satellite cells proliferation and FAPs
adipogenic differentiation. Still, there was a difference involving
THP-1 M2 macrophages, whose conditioned medium did
not decrease FAP adipogenesis to a statistically significant
extent. Finally, our chemotactic tests on HUVECs showed
that migration was cell-type and activation-status-dependent,
but there was a marked difference between MDM and
THP-1 CM. Specifically, all three THP-1 CM induced HUVEC
migration rate at a rate similar to that induced by VEGF
alone. In contrast, CM from M1 and, to a lesser extent,
M2 MDM positively regulated HUVEC migration compared
with resting. These conclusions are in agreement with the
results of our Luminex analyses, as IL-8, RANTES and VEGF-
A, known to have chemoattractant effects on endothelial
cells, were way more abundant in THP-1 than in MDM
CM, independently from the activation state. Overall, our
findings highlight the importance of testing the impact of
macrophage polarized activation not only on functional changes
in macrophages themselves, but also in other cell types mediated
through phenotype- and macrophage model-specific signatures
of secreted factors.
One limitation of this type of study is that any changes in
experimental procedures such as the method used to cultivate
THP-1 cells, the amount of glucose in culture media, criteria of
changing medium, the selection of time points and the methods
used for macrophage polarization (the latter being reviewed
in Murray et al., 2014) might impact on several endpoints.
However, previous studies using experimental conditions other
than those used herein are consistent with the present findings
(Daigneault et al., 2010; Spiller et al., 2016; Shiratori et al.,
2017).
Altogether, our results indicate that THP-1 cells can
indeed respond to the polarization protocols used for
primary macrophages, but to an extent that can greatly vary
depending on the specific endpoint, and that can either
match or diverge from what is seen in human peripheral-
blood MDMs. Therefore, THP-1 cell line reliability as an
alternative model system to primary macrophages should
not be taken for granted but rather confirmed whenever
it is used in a new experimental setting. In addition, the
output of these analyses may be relevant to cell model
selection in immunopharmacology studies and drug screening
programs.
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